Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) shares were up 5.2% during mid-day trading on Wednesday . The company traded as high as $9.80 and last traded at $9.95. Approximately 28,355 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 804,363 shares. The stock had previously closed at $9.45.
Analysts Set New Price Targets
CLMT has been the topic of several analyst reports. HC Wainwright reaffirmed a "buy" rating and set a $33.00 price target on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. TD Cowen downgraded shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their price target for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Wells Fargo & Company lowered their price target on Calumet Specialty Products Partners from $28.00 to $23.00 and set an "overweight" rating for the company in a research report on Wednesday, April 9th. Finally, UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and dropped their target price for the company from $15.00 to $12.00 in a research report on Monday, March 17th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Calumet Specialty Products Partners currently has a consensus rating of "Hold" and a consensus target price of $19.80.
View Our Latest Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Stock Down 5.5 %
The business's 50-day moving average is $12.57 and its two-hundred day moving average is $17.61. The stock has a market capitalization of $792.03 million, a PE ratio of -3.34 and a beta of 1.42.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.59. The firm had revenue of $949.50 million during the quarter, compared to analyst estimates of $921.76 million. Calumet Specialty Products Partners's revenue was down 2.8% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.59) earnings per share. As a group, analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current year.
Insider Buying and Selling at Calumet Specialty Products Partners
In other news, CFO David Lunin purchased 2,500 shares of the firm's stock in a transaction on Tuesday, March 4th. The shares were bought at an average cost of $13.05 per share, with a total value of $32,625.00. Following the purchase, the chief financial officer now directly owns 2,500 shares of the company's stock, valued at approximately $32,625. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stephen P. Mawer sold 3,655 shares of Calumet Specialty Products Partners stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $12.88, for a total transaction of $47,076.40. Following the completion of the sale, the director now directly owns 287,307 shares of the company's stock, valued at $3,700,514.16. The trade was a 1.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.91% of the stock is owned by corporate insiders.
About Calumet Specialty Products Partners
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Articles
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.